Dr. Jeffrey Elting Deyo

MD, PHD | Pediatric Hematology-Oncology | Male

Dr. Jeffrey Elting Deyo, MD, PHD is a Baton Rouge, Louisiana based Pediatric doctor with medical specialization in Pediatric Hematology-Oncology. Current practice location of Dr. Jeffrey Elting Deyo is 8300 Constantin Blvd, Baton Rouge, Louisiana - 70809-3489. He can be contacted on phone at 225-763-6337 and fax number 225-374-4661. Dr. Jeffrey Elting Deyo is a sole proprietor of his business.
NPI number (Unique professional ID) for Dr. Jeffrey Elting Deyo is 1619962032 which was assigned by NPPES on 12 Sep, 2005 and it was last updated on 31 Aug, 2021. Dr. Jeffrey Elting Deyo license number is 15187R for Pediatrics Pediatric Hematology-Oncology (2080P0207X) in Louisiana.
Dr. Jeffrey Elting Deyo is trained in the combination of pediatrics, hematology and oncology to recognize and manage pediatric blood disorders and cancerous diseases.
Complete Profile:
Dr. Jeffrey Elting Deyo basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics Pediatric Hematology-Oncology
Provider Name :Dr. Jeffrey Elting Deyo
Credential :MD, PHD
Gender :Male
Business Address:
Dr. Jeffrey Elting Deyo address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :8300 Constantin Blvd
Baton Rouge, LA, 70809-3489
United States
Phone Number :225-763-6337
Fax Number :225-374-4661
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1619962032
NPI Entity Type : Individual
First Enrolment Date : 12 Sep, 2005
Last Updated On : 31 Aug, 2021
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jeffrey Elting Deyo are as mentioned. Primary taxonomy code for Dr. Jeffrey Elting Deyo, MD, PHD is 2080P0207X (Pediatrics Pediatric Hematology-Oncology).
Taxonomy Code SpecialityPrimaryLicense No.State
208000000XPediatricsNo15187RLA
2080P0207XPediatrics Pediatric Hematology-OncologyYes15187RLA
Legacy Identifiers:
Other legacy medical identifiers of Dr. Jeffrey Elting Deyo such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned below.
IdentifierIdentifier TypeStateIssuer
1193500MEDICAIDLA
Other Practice Locations:
Practice AddressCity, StatePhone Number
5000 AMBASSADOR CAFFERY PKWY STE 101,
LAFAYETTE, LA, 70508-6984
United States
LAFAYETTE, LA225-763-6337
Endpoints:
Endpoints provide a simple, secure, scalable, and standards-based way for participants to send authenticated, encrypted health information directly to known, trusted recipients over the Internet. It is used by EHR systems (Electronic Health Records).
Endpoint TypeEndpointAffiliationUseContentAddress
DIRECT
(Direct Messaging Address)
tdevraj64163@direct.casso.us.com

FMOLHS-Epic
No affiliationDIRECT
Direct
OTHER
Other
tdevraj64163@direct.casso.us.com
8300 CONSTANTIN BLVD,
BATON ROUGE, LA, 70809-3489
United States
FHIR
(FHIR URL)
https://epicproxy.et0830.epihosted.com/FHIRPoxy/api/FHIR/DSTU2/

FMOLHS FHIR URL
No affiliationOTHER
Other
FHIR API
OTHER
Other
C-CDA
8300 CONSTANTIN BLVD,
BATON ROUGE, LA, 70809-3489
United States
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :5959 S Sherwood Forest Blvd
Baton Rouge, LA, 70816-6038
United States
Phone Number :225-526-0002
Fax Number :225-765-9196
Business Location:
Patients can refer following map for directions to Dr. Jeffrey Elting Deyo practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.